State Street Corp Acquires 48,114 Shares of Renovaro Inc. (NASDAQ:RENB)

State Street Corp grew its stake in shares of Renovaro Inc. (NASDAQ:RENB) by 3.8% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,323,832 shares of the company’s stock after purchasing an additional 48,114 shares during the quarter. State Street Corp owned approximately 0.82% of Renovaro worth $640,000 at the end of the most recent quarter.

Separately, Bank of New York Mellon Corp purchased a new stake in Renovaro in the 2nd quarter valued at about $220,000. 71.41% of the stock is currently owned by institutional investors and hedge funds.

Renovaro Price Performance

Shares of RENB stock opened at $0.93 on Friday. The company’s 50-day simple moving average is $0.92 and its two-hundred day simple moving average is $0.90. Renovaro Inc. has a one year low of $0.40 and a one year high of $5.25. The company has a market capitalization of $146.97 million, a P/E ratio of -0.96 and a beta of 0.65.

Renovaro (NASDAQ:RENB) last released its quarterly earnings data on Thursday, October 10th. The company reported ($0.45) EPS for the quarter.

Renovaro Company Profile

Renovaro Inc, a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), and cancer in the United States. The company’s product pipeline includes RENB-HV-01 for autologous HIV curative treatment; RENB-HV-12, a therapeutic HIV vaccine; and RENB-HB-01, a gene therapy curative treatment for HBV.